Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Plasma Darman Sarve Sepid is an Iranian medical technology company specializing in the development and commercialization of Cold Atmospheric Plasma (CAP) devices. The company's flagship technology, marketed under the brand Medopad, utilizes ionized gas at room temperature to treat chronic and non-healing wounds through antimicrobial action and the stimulation of tissue regeneration. Their products are primarily indicated for diabetic foot ulcers, pressure sores, and complex surgical wounds, offering a non-invasive alternative to traditional wound care. Beyond wound management, the company is expanding its plasma technology platform into applications for dermatology and dentistry. Plasma Darman Sarve Sepid operates as a knowledge-based enterprise, collaborating closely with Iranian academic institutions to advance the field of plasma medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Plasma Darman Sarve Sepid.